Cargando…

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants

BACKGROUND: The objective was to develop a risk scoring tool which predicts respiratory syncytial virus hospitalisation (RSVH) in moderate‐late preterm infants (32‐35 weeks’ gestational age) in the Northern Hemisphere. METHODS: Risk factors for RSVH were pooled from six observational studies of infa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanken, Maarten O., Paes, Bosco, Anderson, Evan J., Lanari, Marcello, Sheridan‐Pereira, Margaret, Buchan, Scot, Fullarton, John R., Grubb, ElizaBeth, Notario, Gerard, Rodgers‐Gray, Barry S., Carbonell‐Estrany, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099524/ https://www.ncbi.nlm.nih.gov/pubmed/29405612 http://dx.doi.org/10.1002/ppul.23960

Ejemplares similares

Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons
por: Anderson, Evan J., et al.
Publicado: (2017)

Burden of respiratory syncytial virus hospitalisation among infants born at 32–35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies
por: Lanari, M., et al.
Publicado: (2020)

Association between respiratory syncytial virus hospitalization in infancy and childhood asthma
por: Coutts, Jonathan, et al.
Publicado: (2020)

Clinical burden of severe respiratory syncytial virus infection during the first 2 years of life in children born between 2000 and 2011 in Scotland
por: Thwaites, Richard, et al.
Publicado: (2020)

A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29–35 weeks’ gestational age
por: Keary, Ian P., et al.
Publicado: (2023)

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33–35 weeks of gestational age, based on data from the Spanish FLIP study
por: Simões, Eric AF, et al.
Publicado: (2008)

Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS])
por: Carbonell‐Estrany, Xavier, et al.
Publicado: (2018)

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children
por: Simões, Eric A. F., et al.
Publicado: (2018)

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood
por: Fauroux, Brigitte, et al.
Publicado: (2017)

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries
por: Bont, Louis, et al.
Publicado: (2016)

Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases
por: Manzoni, Paolo, et al.
Publicado: (2017)

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease
por: Paes, Bosco, et al.
Publicado: (2016)

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease
por: Checchia, Paul A., et al.
Publicado: (2017)

Burden of Respiratory Syncytial Virus Hospitalizations in Canada
por: Mitchell, Ian, et al.
Publicado: (2017)

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease
por: Figueras-Aloy, Josep, et al.
Publicado: (2016)

Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease
por: Carbonell-Estrany, Xavier, et al.
Publicado: (2002)

The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children
por: Simões, Eric A.F., et al.
Publicado: (2010)

Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection
por: Vandini, Silvia, et al.
Publicado: (2017)

Respiratory Syncytial Virus Infections in Infants Affected by Primary Immunodeficiency
por: Lanari, Marcello, et al.
Publicado: (2014)

Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants—The SPRING Study
por: Carbonell-Estrany, Xavier, et al.
Publicado: (2015)

The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection
por: Lanari, Marcello, et al.
Publicado: (2013)

Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005–2017
por: Kim, Doyoung, et al.
Publicado: (2019)

Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus
por: Vandini, Silvia, et al.
Publicado: (2015)

Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
por: Sanchez-Luna, M., et al.
Publicado: (2017)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
por: Biagi, Carlotta, et al.
Publicado: (2020)

A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
por: Paes, B., et al.
Publicado: (2012)

Passive Immunoprophylaxis against Respiratory Syncytial Virus in Children: Where Are We Now?
por: Rocca, Alessandro, et al.
Publicado: (2021)

Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain
por: Schmidt, Ralph, et al.
Publicado: (2017)

Respiratory syncytial virus infection in infants and correlation with meteorological factors and air pollutants
por: Vandini, Silvia, et al.
Publicado: (2013)

Prospective Validation of a Prognostic Model for Respiratory Syncytial Virus Bronchiolitis in Late Preterm Infants: A Multicenter Birth Cohort Study
por: Blanken, Maarten O., et al.
Publicado: (2013)

The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs
por: Roy, Álvaro, et al.
Publicado: (2023)

Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada
por: Mitchell, Ian, et al.
Publicado: (2021)

First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)
por: Wang, Daniel Y., et al.
Publicado: (2017)

Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
por: Blanken, Maarten O., et al.
Publicado: (2017)

Comparison of the Canadian vs. the international risk scoring tool for respiratory syncytial virus prophylaxis in moderate-to-late preterm infants
por: Butt, Michelle, et al.
Publicado: (2023)

RSV hospitalisation and healthcare utilisation in moderately prematurely born infants
por: Shefali-Patel, Deena, et al.
Publicado: (2012)

Incidence and seasonality of respiratory syncytial virus hospitalisations in young children in Denmark, 2010 to 2015
por: Jepsen, Martin T., et al.
Publicado: (2018)

Respiratory syncytial virus hospitalisations among young children: a data linkage study
por: Prasad, Namrata, et al.
Publicado: (2019)

Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009–2017
por: Nazareno, Allen L., et al.
Publicado: (2022)

Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention
por: Chen, Jinghan Jenny, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6c3bph5p56s3l6adchaojvhr84